TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26208230

Group type: EXPERIMENTAL
Intervention: 2 doses of tranexamic acid (TXA) 15 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% NaCl (NSS) or placebo
Number of subjects: 80
Study: 24179982

Group type: EXPERIMENTAL
Intervention: Immediate Group (immediate implant placement and provisionalisation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed Group (immediate socket grafting followed by implant placement and provisionalisation after 4 months)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Immediate Group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed Group
Number of subjects: 50
Study: 21477541

Group type: EXPERIMENTAL
Intervention: Automated tourniquet pressure
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (standard tourniquet pressure)
Number of subjects: 244
Study: 19567910

Group type: EXPERIMENTAL
Intervention: Amoxicillin 40 mg/kg/day in three doses
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 168
Study: 16546635

Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics (Group Ab: 2.4 mIU of intramuscular penicillin G benzathine or 5-7 day regimen of oral clindamycin if allergic)
Number of subjects: 181

Group type: COMPARATOR
Intervention: No postoperative antibiotics (Group non-Ab)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Comparison between Group Ab and Group non-Ab
Number of subjects: 181
Study: 16162988

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Stretching protocol
Number of subjects: 60
Study: 12969666

Group type: EXPERIMENTAL
Intervention: Pre-operative abdominal exercises using the Abdotrim abdominal exerciser
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no pre-operative exercises)
Number of subjects: 93
Study: 10662479

Group type: EXPERIMENTAL
Intervention: Amphotericin B plus G-CSF (1 mg/kg daily plus 3 to 5 micrograms/kg daily)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Amphotericin B monotherapy (1 mg/kg daily)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Amphotericin B plus G-CSF
Number of subjects: 59

Group type: COMPARATOR
Intervention: Amphotericin B monotherapy
Number of subjects: 59
Study: 7786939

Group type: EXPERIMENTAL
Intervention: Educational visit and supporting material from a doctor or pharmacist
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (no educational visit)
Number of subjects: 286
Study: 2108529

Group type: EXPERIMENTAL
Intervention: Self-induced pattern-sensitive epilepsy triggers (specific spatial structured stimuli)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Full neurophysiological assessment (baseline EEG recording, activation methods)
Number of subjects: 5
Study: 322793

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 31840522

Group type: EXPERIMENTAL
Intervention: Community Supported Agriculture (CSA) program with 8 biweekly fresh food deliveries and cooking education
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Community Supported Agriculture (CSA) program
Number of subjects: 60
Study: 30369285

Group type: EXPERIMENTAL
Intervention: NHC intervention group (n=7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 14
Study: 28682811

Group type: EXPERIMENTAL
Intervention: Posterior tibial artery
Number of subjects: 234

Group type: COMPARATOR
Intervention: Radial artery
Number of subjects: 234

Group type: COMPARATOR
Intervention: Dorsalis pedis artery
Number of subjects: 234
Study: 26319283

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioural therapy (delivered once a week for 10 weeks)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Physiotherapy exercise (ten sessions over a 6-week period)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioural therapy
Number of subjects: 108
Study: 23889915

Group type: EXPERIMENTAL
Intervention: Thermocool SF(®) catheter with a porous tip (56 holes)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Thermocool(®) catheter with 6 irrigation holes
Number of subjects: 160
Study: 21242484

Group type: EXPERIMENTAL
Intervention: Watchman Left Atrial Appendage System
Number of subjects: 1002
Study: 19321009

Group type: EXPERIMENTAL
Intervention: Quality improvement plan targeting primary health care professionals, including educational sessions, feedback, audit, and implementation of clinical practice guidelines.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 16949348

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba
Number of subjects: 3072

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3072
Study: 15091224

Group type: EXPERIMENTAL
Intervention: High-frequency pulsed electromagnetic energy (Diapulse)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 10695916

Group type: EXPERIMENTAL
Intervention: Pencil-point spinal needle (n=106)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Cutting-point spinal needle (n=109)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Both needle types
Number of subjects: 215

Group type: COMPARATOR
Intervention: Cutting-point needle
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Pencil-point needle
Number of subjects: 215
Study: 9359660

Group type: EXPERIMENTAL
Intervention: Hydroxyurea and didanosine (ddI) combination treatment
Number of subjects: 0
Study: 8243006

Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 76

Group type: COMPARATOR
Intervention: Ioxaglate 320 mg I/ml
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both iodixanol and ioxaglate
Number of subjects: 76
Study: 3985659

Group type: EXPERIMENTAL
Intervention: Nebulised fenoterol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Metered aerosol
Number of subjects: 14
Study: 29566740

Group type: EXPERIMENTAL
Intervention: Filgotinib 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filgotinib 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (add-on therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (monotherapy)
Number of subjects: 0
Study: 28153608

Group type: EXPERIMENTAL
Intervention: Intermittent lower limb occlusion (OCC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (SHAM)
Number of subjects: 16
Study: 25607903

Group type: EXPERIMENTAL
Intervention: Proprietary lightening product
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 80
Study: 23661149

Group type: EXPERIMENTAL
Intervention: Perceived emotional support
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Moderate family contact
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Perceived practical support
Number of subjects: 123
Study: 21507049

Group type: EXPERIMENTAL
Intervention: Targeted multiple interventions
Number of subjects: 1822

Group type: COMPARATOR
Intervention: Standard fall prevention interventions
Number of subjects: 1822
Study: 18032779

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 U/d)
Number of subjects: 1434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1434
Study: 17068701

Group type: EXPERIMENTAL
Intervention: Crosslinked polyethylene (Duration)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Conventional polyethylene
Number of subjects: 127
Study: 14523310

Group type: EXPERIMENTAL
Intervention: Isometric hamstring muscle contractions (MVC) at 30 degrees flexion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 10, 20, 30, 40, 50, 60, 70, 80, and 90% of their three highest averaged MVC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Second day perceived exertion ratings
Number of subjects: 20
Study: 11470718

Group type: EXPERIMENTAL
Intervention: Modified pork with high polyunsaturated fatty acids (PUFAs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard pork
Number of subjects: 20
Study: 9748886

Group type: EXPERIMENTAL
Intervention: Piracetam (12 g i.v. bolus) with Dextran 40 (500 ml daily)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo with Dextran 40 (500 ml daily)
Number of subjects: 47
Study: 7827714

Group type: EXPERIMENTAL
Intervention: Lidocaine (200 to 250 mg loading and 3 mg/min maintenance infusions)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Procainamide (1 gm loading and 3 to 4 mg/min maintenance infusions)
Number of subjects: 27
Study: 3421455

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30772583

Group type: EXPERIMENTAL
Intervention: Repeated GVO plus carvedilol
Number of subjects: 121

Group type: COMPARATOR
Intervention: Repeated GVO
Number of subjects: 121
Study: 28729321

Group type: EXPERIMENTAL
Intervention: Brief structured behavioural intervention
Number of subjects: 205

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Population-based model
Number of subjects: 205

Group type: COMPARATOR
Intervention: Usual care (population-based model)
Number of subjects: 205
Study: 26482258

Group type: EXPERIMENTAL
Intervention: Mean systolic BP ≥ 140 mmHg
Number of subjects: 1448

Group type: EXPERIMENTAL
Intervention: Mean diastolic BP ≥ 80 mmHg
Number of subjects: 1448

Group type: EXPERIMENTAL
Intervention: Mean systolic BP <120 mmHg to ≥150 mmHg
Number of subjects: 1448
Study: 22752958

Group type: EXPERIMENTAL
Intervention: Modified-release prednisone (5 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard prednisolone (5 mg)
Number of subjects: 14
Study: 21471141

Group type: EXPERIMENTAL
Intervention: C trachomatis positive
Number of subjects: 8441

Group type: COMPARATOR
Intervention: C trachomatis negative
Number of subjects: 8441
Study: 18177866

Group type: EXPERIMENTAL
Intervention: 250 microg of recombinant hCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: 7,500 IU of urinary hCG
Number of subjects: 0
Study: 17051589

Group type: EXPERIMENTAL
Intervention: ICAM1 gly241arg (heterozygotes)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: NOS3 glu298asp (heterozygotes)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: NPPA 2238T > C (heterozygotes)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: ADD1 gly460trp (heterozygotes)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: NPPA (homozygote variants)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: ADD1 (homozygote variants)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: NOS3 (smokers with 1 or 2 variant alleles)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: ICAM1 (smokers with 1 or 2 variant alleles)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: NPPA (smokers with 1 or 2 variant alleles)
Number of subjects: 563
Study: 14631461

Group type: EXPERIMENTAL
Intervention: Probiotic beverage containing Lactobacillus casei Shirota (LcS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 10571606

Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prucalopride 1 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study: 8561535

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 28 degrees C
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 32 degrees C
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 37 degrees C
Number of subjects: 45
Study: 1888787

Group type: EXPERIMENTAL
Intervention: Bicitra (sodium citrate and citric acid)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (no Bicitra)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Nausea group (those who experienced nausea)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Non-nausea group (those who were free from nausea)
Number of subjects: 86
Study: 6214441

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 34
Study: 31846558

Group type: EXPERIMENTAL
Intervention: 3D HD endoscopy
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2D HD endoscopy
Number of subjects: 30
Study: 30786095

Group type: EXPERIMENTAL
Intervention: Patient‐Oriented Safe Transition programme (individual discharge planning by case managers, home visits by homecare nurses, telephone calls for one month)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Patient‐Oriented Safe Transition programme
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (standard discharge process)
Number of subjects: 83
Study: 28969890

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri strain DSM 17938 (5 × 10^8 colony-forming units daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (sunflower oil)
Number of subjects: 20
Study: 26159012

Group type: EXPERIMENTAL
Intervention: Danlong Oral Liquid (DOL), 10 mL each time, 3 times per day for 7 days
Number of subjects: 480

Group type: COMPARATOR
Intervention: Kechuanning Oral Liquid (KOL), 10 mL each time, 3 times per day for 7 days
Number of subjects: 480
Study: 23265179

Group type: EXPERIMENTAL
Intervention: Laser Navigation System (LNS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional freehand procedure
Number of subjects: 58
Study: 21982673

Group type: EXPERIMENTAL
Intervention: Oral informed consent
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Written informed consent
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Video informed consent
Number of subjects: 63

Group type: COMPARATOR
Intervention: All formats (oral, written, video)
Number of subjects: 63
Study: 19356104

Group type: EXPERIMENTAL
Intervention: Nevirapine (n=5)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Efavirenz (n=9)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (n=52)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nevirapine/Efavirenz treatment (follow-up patients)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Efavirenz (non-compliance)
Number of subjects: 66
Study: 17069471

Group type: EXPERIMENTAL
Intervention: RS‐86 (M1 mAChR agonist)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15234410

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Intervention to reinstitute CRT
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Atrial tachyarrhythmias
Number of subjects: 512
Study: 10971822

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy
Number of subjects: 998
Study: 8624772

Group type: EXPERIMENTAL
Intervention: Gemfibrozil treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 21
Study: 1379907

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0
Study: 6378233

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg twice daily
Number of subjects: 0
Study: 3742936

Group type: EXPERIMENTAL
Intervention: Triazolam, 0.5 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Triazolam, 0.25 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Flurazepam (dose not specified)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 28669575

Group type: EXPERIMENTAL
Intervention: Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms (TIME)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Brief education-only intervention (Control)
Number of subjects: 229
Study: 27555884

Group type: EXPERIMENTAL
Intervention: Orthèse Diabète (new removable off‐loading orthosis)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (any removable device)
Number of subjects: 117
Study: 24983776

Group type: EXPERIMENTAL
Intervention: Ovarian artery velocimetry in women with spontaneous LH surge
Number of subjects: 130

Group type: COMPARATOR
Intervention: Ovarian artery velocimetry in women needing HCG administration
Number of subjects: 130
Study: 23340148

Group type: EXPERIMENTAL
Intervention: Pharmacist-conducted medication review
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study: 20730517

Group type: EXPERIMENTAL
Intervention: Integrated smoking cessation and binge-drinking intervention (n=22)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard treatment (n=19)
Number of subjects: 41
Study: 18515954

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bisphosphonates
Number of subjects: 0
Study: 16181532

Group type: EXPERIMENTAL
Intervention: Astragalus injection (AI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 72
Study: 14668131

Group type: EXPERIMENTAL
Intervention: Web-based intervention system for periodontal health
Number of subjects: 13

Group type: COMPARATOR
Intervention: Face-to-face toothbrushing instruction and follow-up via telephone (Control)
Number of subjects: 13
Study: 10534247

Group type: EXPERIMENTAL
Intervention: 10,000 U BoNT/B (NeuroBloc) administered in a single session into two to four clinically involved muscles.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 10,000 U BoNT/B (NeuroBloc)
Number of subjects: 77
Study: 8758013

Group type: EXPERIMENTAL
Intervention: Wu Chian‐Ch'uan style Tai Chi
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 126

Group type: COMPARATOR
Intervention: Non-exercise support group
Number of subjects: 126
Study: 1748849

Group type: EXPERIMENTAL
Intervention: Intelligent tutoring system designed using the developed methodology
Number of subjects: 0
Study: 6578788

Group type: EXPERIMENTAL
Intervention: Community treatment with comprehensive support and a 24-hour crisis service
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard hospital care and after-care (Control)
Number of subjects: 120
Study: 31806021

Group type: EXPERIMENTAL
Intervention: Individualized moderate-intensity endurance training for 6 weeks
Number of subjects: 16
Study: 29941991

Group type: EXPERIMENTAL
Intervention: IP6 supplements for 3 months
Number of subjects: 33
Study: 26211605

Group type: EXPERIMENTAL
Intervention: Ergocalciferol (vitamin D2) 50,000 IU twice weekly for 8 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Cholecalciferol (vitamin D3) 50,000 IU weekly for 8 weeks
Number of subjects: 47
Study: 25294376

Group type: EXPERIMENTAL
Intervention: Post-operative cognitive dysfunction (POCD) group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Maximum percentage drop in regional cerebral oxygen saturation (rSO2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: rSO(2, %max) value
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Plasma Aβ levels after 24 h in POCD group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Plasma Aβ levels after 24 h in POCD group vs non-POCD group
Number of subjects: 50
Study: 22524975

Group type: EXPERIMENTAL
Intervention: High lysine diet (80 mgkg(‐1)d(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low lysine diet (∼25 mgkg(‐1)d(‐1) for under-nourished and ∼40 mgkg(‐1)d(‐1) for well-nourished)
Number of subjects: 40
Study: 19158237

Group type: EXPERIMENTAL
Intervention: Physical activity program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary modification program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both physical activity and dietary modification programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home activities
Number of subjects: 0
Study: 17268068

Group type: EXPERIMENTAL
Intervention: FK506 (Tacrolimus); dosage and duration not specified
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (MG(FK-)); no FK506 administration
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (Healthy subjects); no FK506 administration
Number of subjects: 28
Study: 16119511

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefepime 4 g/d
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intermittent administration of cefepime 2 x 2 g
Number of subjects: 50
Study: 11368700

Group type: EXPERIMENTAL
Intervention: Surgery (distal chevron osteotomy)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Orthosis
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control (1-year waiting list)
Number of subjects: 209
Study: 9385488

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg QD
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: lansoprazole 15 mg QD
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg QD
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg QID
Number of subjects: 29
Study: 8187316

Group type: COMPARATOR
Intervention: Placebo treatment (Group 1)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg three times daily (Group 2)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg three times daily (Group 3)
Number of subjects: 34
Study: 3108170

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (900-1,200 mg/day for 4 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 28
Study: 30395486

Group type: EXPERIMENTAL
Intervention: 80 mg atomoxetine plus 5 mg oxybutynin (ato-oxy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: 80 mg atomoxetine
Number of subjects: 20

Group type: COMPARATOR
Intervention: 5 mg oxybutynin
Number of subjects: 20
Study: 26790987

Group type: EXPERIMENTAL
Intervention: Cancer-Related Symptoms
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Functional Impairment
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Cancer-Related Symptoms mediated by Functional Impairment
Number of subjects: 1138
Study: 25795507

Group type: EXPERIMENTAL
Intervention: Dual-site biventricular pacing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single-site biventricular pacing
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nonimplanted control group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pacing intervention (both dual-site and single-site)
Number of subjects: 120